Floatz logo

Levoleucovorin

Unspecified Adult Solid Tumor, Protocol Specific

National Cancer Institute (NCI)Phase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
89/ 100

Competitive context

13 Active assets in the Unspecified Adult Solid Tumor, Protocol Specific cohort.

Asset / SponsorPhaseRating
NEPENTHE
M.D. Anderson Cancer Center
Phase 4BBB
Amifostine
M.D. Anderson Cancer Center
Phase 4BBB
ETOPOSIDE
University of California, Davis
Phase 2/3BBB
FLUTICASONE
Barbara Ann Karmanos Cancer Institute
Phase 2BBB
DEXAMETHASONE
Alliance for Clinical Trials in Oncology
Phase 3BBB

View all 50 →

Same molecule, other indications

Levoleucovorin is also rated in:

gastroesophageal junction adenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
Advanced/Metastatic Gastroesophageal AdenocarcinomaDormant
BB
Indicative ·
68 / 100
View asset →
colorectal cancerDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →